High CD8+ T Cell Activation and Its Impact on HIV-1 Specific Responses
Author Information
Author(s): Jason D. Barbour, Lishomwa C. Ndhlovu, Qi Xuan Tan, Terence Ho, Lorrie Epling, Barry M. Bredt, Jay A. Levy, Frederick M. Hecht, Elizabeth Sinclair, Derya Unutmaz
Primary Institution: University of California San Francisco
Hypothesis
Anti-retroviral suppression of T cell activation levels would lead to alterations in the T cell differentiation of total and HIV-1 specific CD8+ T cell responses among recently HIV-1 infected adults.
Conclusion
A more differentiated, less activated HIV-1 specific CD8+ T cell response may be clinically protective, but anti-retroviral treatment did not alter the differentiation profile of these cells.
Supporting Evidence
- Participants with higher late memory HIV-1-specific CD8+ T cells had higher CD4+ T cell counts.
- High total CD8+ T cell activation was associated with poorer long-term clinical outcomes.
- The differentiation profile of HIV-1 specific T cells was not altered by anti-retroviral treatment.
Takeaway
This study looked at how T cells respond to HIV and found that having more mature T cells can help fight the virus better, but just taking medicine to lower the virus doesn't change how these T cells develop.
Methodology
A longitudinal study measuring T cell activation and maturation markers on total and antigen-specific T cells in recently infected adults before and after anti-retroviral therapy.
Potential Biases
Potential bias due to the small sample size and the specific demographic of participants.
Limitations
The study was limited to a small sample size and focused on a specific time frame post-infection.
Participant Demographics
All participants were treatment-naïve adults in early HIV infection, predominantly male (100%), with a median age of 32 years.
Statistical Information
P-Value
0.004
Confidence Interval
(490, 671)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website